Is a complete CSE/OMND research report available?

No complete published report is available for cse/OMND (CSE/OMND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/OMND (CSE/OMND)

Canadian Securities Exchange: CSE/OMND · CAD

CA$0.01

-0.01 (-50.0%)· Recorded snapshot

Market cap	515.7K
Revenue (ttm)	121.3K
Net income (ttm)	-117.9K
EPS (ttm)	-CA$0.00
Shares out	103.1M
Volume	50,000
Beta	0.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 121.3K
Net income (ttm): -117.9K
EPS (ttm): -CA$0.00
Market cap: 515.7K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-07 02:00 UTC

All CSE/OMND indicators

Market & fundamental data

Available fields

126

Groups with data

Currency

CAD

Showing 126 of 126 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 530,092
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	22.31
Isin	CA68405U1012
Last refreshed	2026-09-07
Market cap	CAD 515,742
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	8000
Symbol	cse/OMND
Website	https://optimindpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.87%
EV/Sales	4.37x
P/B ratio	-2.76x
P/S ratio	4.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-35.27%
Gross margin	62.33%
Gross Profit	CAD 75,602
Gross Profit Growth	9.61%
Gross Profit Growth Q	-7.99%
Gross Profit Growth3 Y	13.38%
Net Income	CAD -117,935
Net Income Growth Years	3%
Pretax Margin	-97.23%
Profit Margin	-97.23%
ROA	-15.61
ROCE	22.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr3y	-56.31%
EPS Growth Years	3
Revenue Growth	2.47x
Revenue Growth Q	-29.36x
Revenue Growth Qo Q	-27.96x
Revenue Growth Years	1x
Revenue Growth3 Y	-10.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.71
Assets	CAD 142,551
Cash	CAD 99,369
Current Assets	CAD 142,551
Current Liabilities	CAD 329,515
Debt	CAD 120,637
Equity	CAD -186,964
Liabilities	CAD 329,515
Long Term Assets	CAD 0
Long Term Liabilities	CAD 0
Net Cash	CAD -21,268
Net Cash By Market Cap	CAD -4.12
Tangible Book Value	CAD -186,964
Tangible Book Value Per Share	CAD -0
WACC	4.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.43
Net Working Capital	CAD -165,696
Quick ratio	0.43
Working Capital	CAD -186,964
Working Capital Turnover	CAD -0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	7.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
3Y total return	-91.67%
50-day SMA	0.01
All Time High	0.2
All Time High Change	-97.5%
All Time High Date	2022-08-04
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2023-11-29
ATR	0
Beta	0.14
Beta1y	0
Beta2y	-1.78
High	0.01
High52	0.01
High52 Date	2025-08-18
High52ch	-50%
Low	0.01
Low52	0.01
Low52 Date	2025-09-11
Low52ch	0%
Ma50ch	-20.63%
RSI	45.97
RSI Monthly	35.72
RSI Weekly	28.55
Sharpe ratio	1.08x
Sortino ratio	1.99
Total Return	7.14%
Tr3m	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	103,148,491
Shares Qo Q	0.01%
Shares Yo Y	-7.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	14,795
Average Volume	18,579.55x
Bv Per Share	-0
Ch3m	-50
Ch3y	-91.67
Change	-50%
Change From Open	0
Close	0.01
Days Gap	-50
Dollar Volume	250
Earnings Date	2026-10-27
EBIT	CAD -42,782
EPS	CAD -0
F Score	4
Fiscal Year End	February
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2026-02-28
Ma150	0.01
Ma150ch	-62.41%
Ma20	0.01
Ma20ch	-33.33%
Net CF	15,595
Next Earnings Date	2026-10-27
Open	0.01
P OCF Ratio	33.07
P OCF Ratio SBC	34.86
Price Date	2025-08-19
Relative Volume	2.69x
Revenue	121,293x
SBC By Revenue	0.66x
Share Based Comp	800
Volume	50,000
Z Score	-51

CSE/OMND (CSE/OMND)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/OMND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/OMND indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/OMND

Frequently asked questions